214 related articles for article (PubMed ID: 9685233)
21. Novel and potent oxazolidinone antibacterials featuring 3-indolylglyoxamide substituents.
Takhi M; Singh G; Murugan C; Thaplyyal N; Maitra S; Bhaskarreddy KM; Amarnath PV; Mallik A; Harisudan T; Trivedi RK; Sreenivas K; Selvakumar N; Iqbal J
Bioorg Med Chem Lett; 2008 Sep; 18(18):5150-5. PubMed ID: 18768315
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of chlorhexidine and povidone iodine activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis using a surface test.
Block C; Robenshtok E; Simhon A; Shapiro M
J Hosp Infect; 2000 Oct; 46(2):147-52. PubMed ID: 11049709
[TBL] [Abstract][Full Text] [Related]
23. 3-Bromo-4-(1H-3-indolyl)-2,5-dihydro-1H-2,5-pyrroledione derivatives as new lead compounds for antibacterially active substances.
Mahboobi S; Eichhorn E; Popp A; Sellmer A; Elz S; Möllmann U
Eur J Med Chem; 2006 Feb; 41(2):176-91. PubMed ID: 16375991
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and antibacterial activity of quinolone-based compounds containing a coumarin moiety.
Emami S; Foroumadi A; Faramarzi MA; Samadi N
Arch Pharm (Weinheim); 2008 Jan; 341(1):42-8. PubMed ID: 18072241
[TBL] [Abstract][Full Text] [Related]
25. Discovery of 4-Pyridone derivatives as specific inhibitors of enoyl-acyl carrier protein reductase (FabI) with antibacterial activity against Staphylococcus aureus.
Takahata S; Iida M; Yoshida T; Kumura K; Kitagawa H; Hoshiko S
J Antibiot (Tokyo); 2007 Feb; 60(2):123-8. PubMed ID: 17420562
[TBL] [Abstract][Full Text] [Related]
26. Bactericidal activity of daptomycin, vancomycin, teicoplanin and linezolid against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium using human peak free serum drug concentrations.
Brauers J; Kresken M; Menke A; Orland A; Weiher H; Morrissey I
Int J Antimicrob Agents; 2007 Mar; 29(3):322-5. PubMed ID: 17204403
[TBL] [Abstract][Full Text] [Related]
27. [Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections].
Li JT; Li Y; Wang J;
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):365-74. PubMed ID: 12820911
[TBL] [Abstract][Full Text] [Related]
28. Mechanistic analysis of muraymycin analogues: a guide to the design of MraY inhibitors.
Tanino T; Al-Dabbagh B; Mengin-Lecreulx D; Bouhss A; Oyama H; Ichikawa S; Matsuda A
J Med Chem; 2011 Dec; 54(24):8421-39. PubMed ID: 22085339
[TBL] [Abstract][Full Text] [Related]
29. Lynamicins A-E, chlorinated bisindole pyrrole antibiotics from a novel marine actinomycete.
McArthur KA; Mitchell SS; Tsueng G; Rheingold A; White DJ; Grodberg J; Lam KS; Potts BC
J Nat Prod; 2008 Oct; 71(10):1732-7. PubMed ID: 18842058
[TBL] [Abstract][Full Text] [Related]
30. Potent DNA gyrase inhibitors; novel 5-vinylpyrazole analogues with Gram-positive antibacterial activity.
Tanitame A; Oyamada Y; Ofuji K; Suzuki K; Ito H; Kawasaki M; Wachi M; Yamagishi J
Bioorg Med Chem Lett; 2004 Jun; 14(11):2863-6. PubMed ID: 15125948
[TBL] [Abstract][Full Text] [Related]
31. Antimicrobial activities of naphthazarins from Arnebia euchroma.
Shen CC; Syu WJ; Li SY; Lin CH; Lee GH; Sun CM
J Nat Prod; 2002 Dec; 65(12):1857-62. PubMed ID: 12502328
[TBL] [Abstract][Full Text] [Related]
32. A new class of anti-MRSA and anti-VRE agents: preparation and antibacterial activities of indole-containing compounds.
Yamamoto Y; Kurazono M
Bioorg Med Chem Lett; 2007 Mar; 17(6):1626-8. PubMed ID: 17254785
[TBL] [Abstract][Full Text] [Related]
33. Conformational constraint in oxazolidinone antibacterials. Synthesis and structure-activity studies of (azabicyclo[3.1.0]hexylphenyl)oxazolidinones.
Renslo AR; Jaishankar P; Venkatachalam R; Hackbarth C; Lopez S; Patel DV; Gordeev MF
J Med Chem; 2005 Jul; 48(15):5009-24. PubMed ID: 16033280
[TBL] [Abstract][Full Text] [Related]
34. A novel antibacterial iridoid and triterpene from Caiophora coronata.
Khera S; Woldemichael GM; Singh MP; Suarez E; Timmermann BN
J Nat Prod; 2003 Dec; 66(12):1628-31. PubMed ID: 14695811
[TBL] [Abstract][Full Text] [Related]
35. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and antibacterial activity of a series of alpha-substituted acetylpiperazinyl oxazolidinones.
Wang XJ; Du GJ; Zhao SQ; Yan M; Gu LQ
Chem Biol Drug Des; 2009 Sep; 74(3):276-81. PubMed ID: 19703029
[TBL] [Abstract][Full Text] [Related]
37. Antibacterial effect and toxicity of synthesized salicylanilide derivatives.
Ghazi IM; Mohamed ZA; Ismail SA; Kamal A
Zentralbl Mikrobiol; 1986; 141(3):225-32. PubMed ID: 3094282
[TBL] [Abstract][Full Text] [Related]
38. Transcriptional regulation of the Enterococcus faecium BM4147 vancomycin resistance gene cluster by the VanS-VanR two-component regulatory system in Escherichia coli K-12.
Haldimann A; Fisher SL; Daniels LL; Walsh CT; Wanner BL
J Bacteriol; 1997 Sep; 179(18):5903-13. PubMed ID: 9294451
[TBL] [Abstract][Full Text] [Related]
39. Novel antibacterial compounds specifically targeting the essential WalR response regulator.
Gotoh Y; Doi A; Furuta E; Dubrac S; Ishizaki Y; Okada M; Igarashi M; Misawa N; Yoshikawa H; Okajima T; Msadek T; Utsumi R
J Antibiot (Tokyo); 2010 Mar; 63(3):127-34. PubMed ID: 20111065
[TBL] [Abstract][Full Text] [Related]
40. Spiromastixones A-O, antibacterial chlorodepsidones from a deep-sea-derived Spiromastix sp. fungus.
Niu S; Liu D; Hu X; Proksch P; Shao Z; Lin W
J Nat Prod; 2014 Apr; 77(4):1021-30. PubMed ID: 24571273
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
